DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)

Product Overview

About DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)

DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF) is a sterile, injectable pharmaceutical product designed for clinical use. This medication is formulated as a solution for intravenous or intramuscular administration. It serves as a derivative of folic acid and is essential for various therapeutic protocols where the modulation of folate metabolism is required. The product is manufactured to meet United States Pharmacopeia standards, ensuring consistency and quality for healthcare providers. It is supplied in a vial format intended for professional medical application within hospital or clinical settings.

Key Benefits & Uses

• Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination.
• Acts as a rescue agent in high-dose methotrexate therapy protocols.
• Provides a source of reduced folate to support cellular metabolic processes.

Active Ingredient & Action

The active ingredient in this medication is calcium folinate. Unlike folic acid, calcium folinate does not require activation by the enzyme dihydrofolate reductase to function within the body. It effectively bypasses metabolic blocks, allowing for the replenishment of folate pools and the mitigation of specific drug-induced folate deficiencies.

Important Notes

This product must be administered under the supervision of a qualified healthcare professional. Always verify the dosage and administration route against the specific clinical requirements of the patient. Store the vials according to the manufacturer's temperature specifications to maintain product integrity.